These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22187403)

  • 1. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis.
    Kenet G; Aronis S; Berkun Y; Bonduel M; Chan A; Goldenberg NA; Holzhauer S; Iorio A; Journeycake J; Junker R; Male C; Manco-Johnson M; Massicotte P; Mesters R; Monagle P; van Ommen H; Rafini L; Simioni P; Young G; Nowak-Göttl U
    Semin Thromb Hemost; 2011 Oct; 37(7):802-9. PubMed ID: 22187403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.
    Young G; Albisetti M; Bonduel M; Brandao L; Chan A; Friedrichs F; Goldenberg NA; Grabowski E; Heller C; Journeycake J; Kenet G; Krümpel A; Kurnik K; Lubetsky A; Male C; Manco-Johnson M; Mathew P; Monagle P; van Ommen H; Simioni P; Svirin P; Tormene D; Nowak-Göttl U
    Circulation; 2008 Sep; 118(13):1373-82. PubMed ID: 18779442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies.
    Kenet G; Lütkhoff LK; Albisetti M; Bernard T; Bonduel M; Brandao L; Chabrier S; Chan A; deVeber G; Fiedler B; Fullerton HJ; Goldenberg NA; Grabowski E; Günther G; Heller C; Holzhauer S; Iorio A; Journeycake J; Junker R; Kirkham FJ; Kurnik K; Lynch JK; Male C; Manco-Johnson M; Mesters R; Monagle P; van Ommen CH; Raffini L; Rostásy K; Simioni P; Sträter RD; Young G; Nowak-Göttl U
    Circulation; 2010 Apr; 121(16):1838-47. PubMed ID: 20385928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies.
    Bidlingmaier C; Kenet G; Kurnik K; Mathew P; Manner D; Mitchell L; Krümpel A; Nowak-Göttl U
    Semin Thromb Hemost; 2011 Oct; 37(7):814-25. PubMed ID: 22187405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis.
    Ortel TL; Meleth S; Catellier D; Crowther M; Erkan D; Fortin PR; Garcia D; Haywood N; Kosinski AS; Levine SR; Phillips MJ; Whitehead N
    J Thromb Haemost; 2020 Sep; 18(9):2274-2286. PubMed ID: 32484606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between ABO blood types and venous thromboembolism in individuals with a positive antiphospholipid profile is varied by sex.
    Shusterman M; Golub E; Mowrey WB; Broder A
    Lupus; 2018 Feb; 27(2):319-326. PubMed ID: 28705035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study.
    Pengo V; Ruffatti A; Legnani C; Testa S; Fierro T; Marongiu F; De Micheli V; Gresele P; Tonello M; Ghirarduzzi A; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    Blood; 2011 Oct; 118(17):4714-8. PubMed ID: 21765019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis.
    Wahl DG; Guillemin F; de Maistre E; Perret-Guillaume C; Lecompte T; Thibaut G
    Lupus; 1998; 7(1):15-22. PubMed ID: 9493144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody profiles for the diagnosis of antiphospholipid syndrome.
    Pengo V; Biasiolo A; Pegoraro C; Cucchini U; Noventa F; Iliceto S
    Thromb Haemost; 2005 Jun; 93(6):1147-52. PubMed ID: 15968401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
    Amory CF; Levine SR; Brey RL; Gebregziabher M; Tuhrim S; Tilley BC; Simpson AC; Sacco RL; Mohr JP;
    Cerebrovasc Dis; 2015; 40(5-6):293-300. PubMed ID: 26513489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Cheng CY; Zhang YX; Denas G; Du Y; Jing ZC; Pengo V
    Intern Emerg Med; 2019 Jun; 14(4):521-527. PubMed ID: 30603858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies and lower extremity peripheral arterial disease - a systematic review and meta-analysis.
    Gavier B; Vazquez F; Gandara E
    Vasa; 2016; 45(4):325-30. PubMed ID: 27428502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of antiphospholipid antibody in pediatric patients and review of literature].
    Xiao HJ; Yang JY; Gao TJ; Huang JP; Yao Y; Zhang Y
    Zhonghua Er Ke Za Zhi; 2004 Aug; 42(8):571-3. PubMed ID: 15347440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis.
    Sofi F; Marcucci R; Abbate R; Gensini GF; Prisco D
    Am J Med; 2007 Aug; 120(8):728-33. PubMed ID: 17679133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine, antiphospholipid antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martínez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Rueda M; Aguirre C
    Lupus; 2004; 13(12):927-33. PubMed ID: 15645748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant perinatal thrombosis and antiphospholipid antibodies: a review.
    Boffa MC; Lachassinne E
    Lupus; 2007; 16(8):634-41. PubMed ID: 17711900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Length of exposure to antiphospholipid antibodies, rather than age, is a risk factor for thrombosis: a retrospective single-centre observational study.
    Les I; Parraza N; Anaut P; Eguiluz S; Sánchez C; Preciado ME; Loza JÁ; Andía A
    Rheumatol Int; 2018 Feb; 38(2):229-238. PubMed ID: 29124399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.